Dupont Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-17,528
| Closed | -$8.72M | – | 118 |
|
|
2025
Q1 | $8.72M | Sell |
17,528
-2,208
| -11% | -$1.2M | 0.97% | 46 |
|
|
2024
Q4 | $10.3M | Sell |
19,736
-2,421
| -11% | -$1.33M | 0.96% | 39 |
|
|
2024
Q3 | $13.7M | Hold |
22,157
| – | – | 1.14% | 22 |
|
|
2024
Q2 | $12.3M | Sell |
22,157
-5,989
| -21% | -$3.43M | 1.07% | 24 |
|
|
2024
Q1 | $16.4M | Sell |
28,146
-3,713
| -12% | -$2.08M | 1.35% | 17 |
|
|
2023
Q4 | $16.9M | Buy |
31,859
+4,328
| +16% | +$2.09M | 1.48% | 16 |
|
|
2023
Q3 | $13.9M | Buy |
27,531
+16,009
| +139% | +$8.53M | 1.22% | 18 |
|
|
2023
Q2 | $6.01M | Buy |
11,522
+1,637
| +17% | +$883K | 0.3% | 63 |
|
|
2023
Q1 | $5.7M | Buy |
9,885
+435
| +5% | +$245K | 0.27% | 58 |
|
|
2022
Q4 | $5.2M | Sell |
9,450
-1,258
| -12% | -$667K | 0.25% | 59 |
|
|
2022
Q3 | $5.43M | Sell |
10,708
-12,267
| -53% | -$6.86M | 0.32% | 33 |
|
|
2022
Q2 | $12.5M | Buy |
22,975
+1,582
| +7% | +$871K | 0.58% | 17 |
|
|
2022
Q1 | $12.6M | Sell |
21,393
-1,049
| -5% | -$603K | 0.51% | 20 |
|
|
2021
Q4 | $15M | Buy |
22,442
+3,951
| +21% | +$2.47M | 0.53% | 20 |
|
|
2021
Q3 | $10.6M | Sell |
18,491
-12,580
| -40% | -$6.9M | 0.33% | 44 |
|
|
2021
Q2 | $15.7M | Buy |
31,071
+3,754
| +14% | +$1.77M | 0.37% | 42 |
|
|
2021
Q1 | $12.5M | Sell |
27,317
-3,449
| -11% | -$1.65M | 0.3% | 50 |
|
|
2020
Q4 | $14.3M | Sell |
30,766
-4,018
| -12% | -$1.88M | 0.3% | 59 |
|
|
2020
Q3 | $15.4M | Buy |
34,784
+8,069
| +30% | +$3.33M | 0.34% | 54 |
|
|
2020
Q2 | $9.68M | Sell |
26,715
-1,644
| -6% | -$551K | 0.21% | 87 |
|
|
2020
Q1 | $8.04M | Buy |
28,359
+8,719
| +44% | +$2.75M | 0.19% | 93 |
|
|
2019
Q4 | $6.38M | Buy |
19,640
+3,760
| +24% | +$1.14M | 0.14% | 122 |
|
|
2019
Q3 | $4.63M | Sell |
15,880
-1,948
| -11% | -$558K | 0.11% | 162 |
|
|
2019
Q2 | $5.24M | Sell |
17,828
-8,961
| -33% | -$2.47M | 0.12% | 161 |
|
|
2019
Q1 | $7.33M | Sell |
26,789
-2,732
| -9% | -$680K | 0.17% | 112 |
|
|
2018
Q4 | $6.61M | Buy |
29,521
+684
| +2% | +$160K | 0.16% | 115 |
|
|
2018
Q3 | $7.04M | Sell |
28,837
-1,229
| -4% | -$283K | 0.16% | 122 |
|
|
2018
Q2 | $6.23M | Buy |
30,066
+23,536
| +360% | +$5M | 0.15% | 127 |
|
|
2018
Q1 | $1.35M | Sell |
6,530
-5,248
| -45% | -$1.1M | 0.03% | 433 |
|
|
2017
Q4 | $2.24M | Sell |
11,778
-906
| -7% | -$174K | 0.05% | 327 |
|
|
2017
Q3 | $2.4M | Sell |
12,684
-397
| -3% | -$71.9K | 0.05% | 317 |
|
|
2017
Q2 | $2.28M | Buy |
13,081
+1,978
| +18% | +$332K | 0.05% | 327 |
|
|
2017
Q1 | $1.71M | Sell |
11,103
-227
| -2% | -$34.7K | 0.04% | 387 |
|
|
2016
Q4 | $1.6M | Buy |
11,330
+2,170
| +24% | +$320K | 0.04% | 370 |
|
|
2016
Q3 | $1.46M | Buy |
+9,160
| New | +$1.41M | 0.03% | 368 |
|
|
2014
Q2 | – | Sell |
-2,600
| Closed | -$313K | – | 684 |
|
|
2014
Q1 | $313K | Buy |
+2,600
| New | +$309K | 0.01% | 604 |
|
Other funds holding TMO
Dupont Capital Management's TMO Position: Q2 2025 in Review
Dupont Capital Management sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 17,528 shares — an estimated $8.72M sold.
Dupont Capital Management first reported a position in TMO in Q1 2014 and held it in 36 quarters. The position peaked at $16.9M in Q4 2023. 2,453 funds tracked by Wall St. Rank hold TMO as of Q2 2025.
- Dupont Capital Management reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
- Dupont Capital Management sold 17,528 Thermo Fisher Scientific shares in Q2 2025, an estimated $8.72M.
- Dupont Capital Management first reported a position in Thermo Fisher Scientific in Q1 2014 and held it in 36 quarters.
- Dupont Capital Management's Thermo Fisher Scientific position peaked at $16.9M in Q4 2023.
- 2,453 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.
Based on Dupont Capital Management's 13F filing for Q2 2025, filed 30 Jul 2025.